Diroximel fumarate for brain bleed swelling
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a medicine called diroximel fumarate to reduce swelling around a bleeding stroke (intracerebral hemorrhage). If you or your loved one have had a brain bleed within the last 48 hours and are not too severely affected, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- The brain bleed must be within the first 48 hours and not require immediate surgery.
- You cannot be taking a similar medication (dimethyl fumarate) for another condition.
- You must not have a severe swallowing problem that requires a feeding tube.
- You must be able to give informed consent and have French health insurance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a drug called Cerebrolysin, which may help protect the brain after a bleeding stroke. It is given within 6 hours of the stroke, and researchers will check if it is safe and helps improve recovery.
This trial tests whether an investigational study drug can improve outcomes after an acute ischemic stroke (a stroke caused by blocked blood flow). You may be eligible if you are able to start treatment quickly after symptom onset and have a moderate stroke severity on a standard stroke exam.
This trial tests whether a drug called Recombinant Factor VIIa (rFVIIa) can safely help stop bleeding in the brain during a hemorrhagic stroke. The goal is to give the drug as quickly as possible, within 2 hours of stroke onset, to see if it improves outcomes.
This trial compares two medicines (deferoxamine and colchicine) to see if they can prevent further brain damage after a spontaneous brain bleed (intracerebral hemorrhage). The goal is to improve recovery by reducing inflammation and iron-related damage.
This study tests a combination of a minimally invasive surgery to remove the brain bleed and a medication called deferoxamine (which may help reduce damage from the bleed). The goal is to see if this combination helps improve recovery after a brain hemorrhage.
This study looks at how inflammation and the brain's protective barrier are affected after a hemorrhagic stroke. It uses special brain scans to see these changes, which might help guide future care.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.